Investing.com - Erytech Pharma ADR reported on Tuesday first quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Erytech Pharma ADR announced earnings per share of $-0.9566 on revenue of $2.29M. Analysts polled by Investing.com anticipated EPS of $-0.9632 on revenue of $2.32M.
Erytech Pharma ADR shares are up 30.23% from the beginning of the year, still down 49.75% from its 52 week high of $13.95 set on August 11, 2020. They are outperforming the S&P 500 which is up 10.86% from the start of the year.
Erytech Pharma ADR follows other major sector earnings this month
Erytech Pharma ADR's report follows an earnings beat by Industrial Commercial Bank of China on April 29, who reported EPS of $0.7417 on revenue of $33.09B, compared to forecasts EPS of $0.6343 on revenue of $34.72B.
L’Oreal ADR had matched expectations on April 15 with first quarter EPS of $1.03 on revenue of $9.12B, compared to forecast for EPS of $1.03 on revenue of $9.23B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar